Somaxon To Put Silenor Phase III Program To Bed In December
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm's Q3 2007 filing timeframe puts it ahead of Neurocrine's resubmission plans for immediate-release indiplon.